Ampuero J, Morillas R, Cantero H, de Pedro S, Mareque M
Economic burden of Primary Biliary Cholangitis (PBC) in Spain
Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow (Escocia). 9-12 nov 2025
Bustamante-Balén M, Merino Rodríguez B, Barranco Priego L, Monje J, Álvarez M, de Pedro S, Oyagüez I, Van Lent N, Mareque M
Cost-effectiveness and budget impact analysis of introducing artificial intelligence-aided colonoscopy for adenoma detection and characterization in Spain
27th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 17-19 nov 2024
Oyagüez I, Bellido Castañeda V, Ampudia-Blasco FJ, Carretero Gómez J, Cebrián Cuenca A, Gómez Peralta F, Hernández Martínez AM, Mezquita-Raya P
Cost-utility analysis of Flash Glucose Monitoring Systems in people with type 2 diabetes mellitus and poor glycaemic control on basal insulin from the Spanish health system perspective
27th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 17-19 nov 2024
Ortiz-Maldonado V, Presa M, Tejado N, Pardo C, Martín-Escudero V, Oyagüez I, Martín A
Axicabtagene Ciloleucel As Second-Line Treatment For Relapsed/ Refractory Large B-Cell Lymphoma In Spain: A Cost-Effectiveness Analysis Refractory Large B-Cell Lymphoma In Spain: A Cost-Effectiveness Analysis
26th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 12-15 nov 2023
Peral C, de Lossada Juste A, Lwoff N, Espinoza Cámac N, Martínez-Martínez N, Casado MÁ, Burke T, Kane A, Alvir J, Thakkar S, Ferri Grazzi E
Economic Burden of Moderate and Severe Hemophilia A and B in Spain, Real-World Evidence Insights from the Cost of Hemophilia in Europe: A Socio-Economic Survey II (CHESS II) Study
26th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 12-15 nov 2023
Parramon M, Juárez M, de Pedro S, Echave M, Oyagüez I, Casado MÁ, Martínez-Salamanca JI
Cost Analysis of Prostav®: A New Telomere-Based Biomarker for the Early Detection of Prostate Cancer Available in Europe
26th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 12-15 nov 2023
Córdoba R, López-Corral L, Presa M, Martín-Escudero V, Casado MÁ, Pardo C
Value of Axicabtagene Ciloleucel Versus Chemotherapy in the Large B-Cell Lymphoma Treatment: Health Outcomes Based on the Number of Patients Treated in Spain
25th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Viena (Austria). 06-09 nov 2022
Presa M, Vicente D, Calles A, Salinas-Ortega L, Naik J, García LF, Soto J
Lorlatinib as a first-line treatment for ALK+ advanced Non-Small Cell Lung Cancer: a cost-effectiveness analysis in Spain
25th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Viena (Austria). 06-09 nov 2022
Bastos-Oreiro M, de las Heras A, Presa M, Casado MA, Pardo C, Martín-Escudero V, Sureda A